When asked the question of how Inteliquet can help clinical trials succeed, CEO Carla Balch did not hesitate.
Carla said Inteliquet, as a technology innovator, is capable of “Screening Every Patient, Every Night, for Every Trial.”
She also noted that the more patients you can screen for clinical trials, the more patients can be approached.
Carla wants Inteliquet to fix the broken healthcare workflow, which involves making clinical trials part of that workflow for cancer patients.
You can watch her entire interview here.
HOW NEW THERAPIES REACH PATIENTS FASTER